Skip to main content
. 2023 Jan 30;15(3):846. doi: 10.3390/cancers15030846

Figure 2.

Figure 2

Overall survival (OS) for total cases treated with stereotactic body radiation therapy (SBRT) and repeated cases treated with SBRT. (a) OS for total cases (median survival time (MST), 52 months; 95% confidence interval (CI), 45–64 months). (b) OS for repeated cases. MST from first SBRT was 76 months (95% CI, 50–102 months).